Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Liothyronine 20microgram tablets
0602010M0AAAAAA
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | 11,462 |
|
Liothyronine 10microgram capsules
0602010M0AAAUAU
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | 2,424 |
|
Liothyronine 5microgram capsules
0602010M0AAAZAZ
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | 2,076 |
|
Liothyronine 5microgram tablets
0602010M0AAADAD
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | 1,913 |
|
Liothyronine 10microgram tablets
0602010M0AAAQAQ
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | 1,612 |
|
Liothyronine 20microgram capsules
0602010M0AABABA
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | 784 |
|
Liothyronine 2.5microgram capsules
0602010M0AAAIAI
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | 40 |
|
Liothyronine 25microgram tablets
0602010M0AAAWAW
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | 20 |
|
Liothyronine 100micrograms/5ml oral liquid
0602010M0AAAMAM
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 10micrograms/5ml oral suspension
0602010M0AAATAT
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 10micrograms/ml oral solution
0602010M0AABBBB
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 10micrograms/ml oral solution sugar free
0602010M0AABCBC
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 20microgram inj vials
0602010M0AAAVAV
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 20microgram solution for injection ampoules
0602010M0AAABAB
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 20micrograms/5ml oral suspension
0602010M0AAAXAX
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 25micrograms/5ml oral suspension
0602010M0AAAYAY
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 37.5micrograms/5ml oral liquid
0602010M0AAAKAK
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 50microgram tablets
0602010M0AAASAS
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 50micrograms/5ml oral liquid
0602010M0AAALAL
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 5micrograms/5ml oral liquid
0602010M0AAANAN
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.